How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Intended for high school seniors, this annual event will highlight opportunities offered by Smith College for African American, Asian American, Latin American, Native American, and/or first-generation ...

Fireside Chat: The case for Autonomous IT New research shows over half of IT leaders are pursuing agentic AI to improve service quality and manage infrastructure complexity. Most are figuring it out ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...